IntoCell, Inc. (KOSDAQ:287840)
South Korea · Delayed Price · Currency is KRW 20,500
-1,500 (-6.82%)
At close: Jul 20, 2026
IntoCell Market Cap
IntoCell has a market cap or net worth of 307.95 billion as of July 20, 2026. Its market cap has decreased by -19.92% in one year.
Market Cap
307.95B
Enterprise Value
290.75B
Revenue
2.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
20,500.00
ChartMarket Cap Chart
Since May 23, 2025, IntoCell's market cap has decreased from 492.33B to 307.95B, a decrease of -37.45%. That is a compound annual growth rate of -33.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 307.95B | -64.24% |
| Dec 30, 2025 | 861.05B | 74.89% |
| May 23, 2025 | 492.33B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AprilBio | 590.03B |
| Inventage Lab | 446.78B |
| Curocell | 359.33B |
| HansBiomed | 326.59B |
| IMBiologics | 283.79B |
| S.Biomedics | 231.60B |
| Kangstem Biotech | 213.03B |
| curacle co.,ltd. | 188.54B |